Form 4 for MYGN MYRIAD GENETICS INC
Accepted 2021-10-12 00:00:00 ET · period of report 2021-10-09 · accession 0001519749-21-000017 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2021-10-12 | 2021-10-09 | MYGN | Hart Jayne B. | CHRO | F - Tax | $30.88 | -4,926 | 146.2K | -3% | -$152.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-10-09 | F | D | 1,978 | $30.88 | 149,163 | D | — | — | (F2) Includes 41,021 shares of Myriad common stock that were omitted from the reporting person's Form 3, which was amended to reflect such shares on October 12, 2021. |
| 2 | Common | Common Stock | 2021-10-09 | F | D | 2,948 | $30.88 | 146,215 | D | — | — |